Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.62 |
| ▸ | TTR | P02766 | 4/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.62 |
| ▸ | TYR | P14679 | 2/20 | 0.62 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.62 |
| ▸ | BCHE | P06276 | 1/20 | 0.62 |
| ▸ | MMP2 | P08253 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | CTSB | P07858 | 2/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17675282 | 1.00 | APP (0.70) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL17675463 | 0.90 | CYP1A1 (0.67) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL17675461 | 0.90 | CYP1A1 (0.67) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL1603799 | 0.89 | APP (0.87) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL1603801 | 0.89 | APP (0.87) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL5360748 | 0.83 | APP (0.77) | APPMAPTTTRALOX5TYR | |
| SCHEMBL5360751 | 0.83 | APP (0.77) | APPMAPTTTRALOX5TYR | |
| SCHEMBL16213550 | 0.82 | CYP1A1 (0.67) | APPMAPTCYP1A1CYP1B1PTGS1 | |
| SCHEMBL1607405 | 0.82 | APP (1.00) | APPMAPTCYP1A1CYP1B1TTR | |
| SCHEMBL13191839 | 0.82 | APP (1.00) | APPMAPTCYP1A1CYP1B1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4595776-A1 | NUTRITIONAL COMPOSITION FOR CANCER PATIENTS AND ELDERLY SUBJECTS | Pasqualetti, Giuseppe (IT) | 2025-08-06 | — | — | EP | disclosed |
| US-20230145555-A1 | COMPOSITION COMPRISING RESVERATROL | GALENUS G.H. AG (CH) | 2023-05-11 | — | — | US | disclosed |
| US-20220160649-A1 | PHARMACEUTICAL COMPOSITION | DOBMEYER RITA (CH) | 2022-05-26 | — | — | US | disclosed |
| US-10376840-B2 | Process for extraction and separation of oxyresveratrol from Artocarpus lakoocha Roxb | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2019-08-13 | — | — | US | disclosed |
| US-20170296970-A1 | A PROCESS FOR EXTRACTION AND SEPARATION OF OXYRESVERATROL FROM ARTOCARPUS LAKOOCHA ROXB | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-10-19 | — | — | US | disclosed |
| EP-3204346-A1 | A PROCESS FOR EXTRACTION AND SEPARATION OF OXYRESVERATROL FROM ARTOCARPUS LAKOOCHA ROXB | Council of Scientific and Industrial Research (IN) | 2017-08-16 | — | — | EP | disclosed |
| WO-2016056029-A1 | A PROCESS FOR EXTRACTION AND SEPARATION OF OXYRESVERATROL FROM ARTOCARPUS LAKOOCHA ROXB | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160649-A1 | PHARMACEUTICAL COMPOSITION | FGF23, FGFR3, FGFR2 | APP 2837/4885MAPT 2119/4885CYP1A1 652/4885 |
| US-20230145555-A1 | COMPOSITION COMPRISING RESVERATROL | VDR, ACE2, CYP2R1 | APP 1240/4885MAPT 4170/4885CYP1A1 2873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.